Structural properties of phenylethylamine derivatives which inhibit transport-P in peptidergic neurones

British Journal of Pharmacology

Volumn 124, Issue 4, 1998, Pages 693-702

  Al Damluji, S ^a   Kopin, I J ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b NONE

Author keywords

adrenoceptors; Biological transport; Hypothalamus; LHRH; Prazosin; Structure activity relationship

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; PHENETHYLAMINE DERIVATIVE; PHENYL GROUP; PRAZOSIN; TERTIARY AMINE;

ARTICLE; COMPETITIVE INHIBITION; DRUG STRUCTURE; DRUG UPTAKE; PEPTIDERGIC NERVOUS SYSTEM; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ADRENERGIC ALPHA-ANTAGONISTS; ANILINE COMPOUNDS; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE, TRANSFORMED; GONADOTROPIN-RELEASING HORMONE; HYPOTHALAMUS; MICE; NEURONS; PRAZOSIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031806990     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701894     Document Type: Article

References (49)

1. AL-DAMLUJI, S. (1993). Adrenergic control of the secretion of anterior pituitary hormones. In Bailliere's Clinical Endocrinology and Metabolism, vol. 7, part 2, pp. 355-392.
2. AL-DAMLUJI, S. (1996). Verapamil is a substrate for transport-P in peptidergic neurones. J. Endocrinol., 148 (supplement), abstract P138.
3. AL-DAMLUJI, S. & KOPIN, I.J. (1996a). Functional properties of the uptake of amines in immortalised peptidergic neurones (Transport-P). Br. J. Pharmacol., 117, 111-118.
4. AL-DAMLUJI, S. & KOPIN, I.J. (1996b). Binding and competitive inhibition of amine uptake at postsynaptic neurones (transport-P) by tricyclic antidepressants. Br. J. Pharmacol., 117, 811-816.
5. AL-DAMLUJI, S. & KRSMANOVIC, L. (1992). High-affinity uptake of noradrenaline by GnRH cells. Abstracts of the Endocrine Society, 74, 197 (abstract).
6. AL-DAMLUJI, S., KRSMANOVIC, L. & CATT, K.J. (1993). High-affinity uptake of noradrenaline in post-synaptic neurones. Br. J. Pharmacol., 109, 299-307.
7. AL-DAMLUJI, S., PORTER, D., KRSMANOVIC, L., KNUTSON, J.R. & KOPIN, I.J. (1997). Visual detection of transport-P in peptidergic neurones. Br. J. Pharmacol., 120, 876-882.
8. AMARA, S.G. & KUHAR, M.J. (1993). Neurotransmitter transporters: recent progress. Ann. Rev. Neurosci., 16, 73-93.
9. BRYAN, L.J. & O'DONNELL, S.R. (1984). Stereoselectivity of extraneuronal uptake of catecholamines in guinea-pig trachealis smooth muscle cells. Br. J. Pharmacol., 82, 757-762.
10. BURGEN, A.S.V. & IVERSEN, L.L. (1965). The inhibition of noradrenaline uptake by sympathomimetic amines in the rat isolated heart. Br. J. Pharmacol., 25, 34-39.
11. DE LEAN, A., MUNSON, P.J. & RODBARD, D. (1978). Simultaneous analysis of families of sigmoidal curves: application to bioassay. radioligand assay, and physiological dose-response curves. Am. J. Physiol., 235, E97-E102.
12. DEMARINIS, R.M., BRYAN, W.M., SHAH, D.H., HIEBLE, J.P. & PENDLETON, R.G. (1981). Alpha-adrenergic agents. I. Direct-acting alpha-1 agonists related to methoxamine. J. Med. Chem. 24, 1432-1437.
13. FERRIS, R.M., TANG, F.L.M. & MAXWELL, R.A. (1972). A comparison of the capacities of isomers of amphetamine, deoxypipradol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta. J. Pharmacol. Exp. Ther., 181, 407-416.
14. 3H]dopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus. J Pharmacol. Exp. Ther., 210, 422-428.
15. GIROS, B., WANG, Y.M., SUTER, S., MCLESKEY, S.B., PIFL, C. & CARON, M.G. (1994). Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J. Biol. Chem., 269, 15985-15988.
16. 2 in the rat heart. Naunyn-Schmiedeberg's Arch. Pharmacol., 328, 164-173.
17. 3H]-catecholamines by homogenates of rat corpur striatum and cerebral cortex: effects of amphetamine analogues. Neuropharmacology, 12, 669-679.
18. 3H-Normetanephrine uptake in rat brain slices. Relationship to extraneuronal accumulation of norepinephrine. Eur. J. Pharmacol., 12, 167-179.
19. HORN, A.S. (1973). Structure-activity relations for the inhibition of catecholamine uptake into synaptosomes from noradrenaline and dopaminergic neurones in rat brain homogenates. Br. J. Pharmacol., 47, 332-338.
20. HORN, A.S. (1974). The conformation of dopamine at its uptake site: further studies with rigid analogues. J. Pharmac. Pharmacol., 26, 735-737.
21. HORN, A.S. & SNYDER, S.H. (1972). Steric requirements for catecholamine uptake by rat brain synaptosomes: studies with rigid analogs of amphetamine. J. Pharmacol. Exp. Ther., 180, 523-530.
22. ISON, R.R., PARTINGTON, P. & ROBERTS, G.C.K. (1973). The conformation of catecholamines and related compounds in solution. Molec. Pharmacol., 9, 756-765.
23. IVERSEN, L.L., JARROTT, B. & SIMMONDS, M.A. (1971). Differences in the uptake, storage and metabolism of (+)-and ( )-noradrenaline. Br. J. Pharmacol., 43, 845-855.
24. KIMELBERG, H.K. (1986). Occurrence and functional significance of serotonin and catecholamine uptake by astrocytes. Biochem. Pharmacol., 35, 2273-2281.
25. KOE, B.K. (1976). Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J. Pharmacol. Exp. Ther., 199, 649-661.
26. LENTZEN, H. & PHILIPPU, A. (1981). Physico-chemical properties of phenethylamines and their uptake into synaptic vesicles of the caudate nucleus. Biochem. Pharmacol., 30, 1759-1764.
27. LESTER, H.A., MAGER, S., QUICK, M.W. & COREY, J.L. (1994). Permeation properties of neurotransmitter transporters. Ann. Rev. Pharmacol. Toxicol., 34, 219-249.
28. LIU, Y. & EDWARDS, R.H. (1997). The role of vesicular transport proteins in synaptic transmission and neural degeneration. Ann. Rev. Neurosci., 20, 125-156.
29. + toxicity encodes a vesicular amine transporter. Cell, 70, 539-551.
30. MAXWELL, R.A., CHAPLIN, E., BATMANGLIDJ ECKHARDT, S., SOARES, J.R. & HITE, G. (1970). Conformational similarities between molecular models of phenethylamine and of potent inhibitors of the uptake of tritiated norepinephrine by adrenergic nerves in rabbit aorta. J. Pharmacol. Exp. Ther., 173, 158-165.
31. MEIERGERD, S.M. & SCHENK., J.O. (1994). Striatal transport for dopamine: catechol structure-activity studies and susceptibility to chemical modification. J. Neurochem., 62, 998-1008.
32. MELLON, P.L., WINDLE, J.J., GOLDSMITH, P.C., PADULA, C.A., ROBERTS, J.L. & WEINER, R.I. (1990). Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron, 5, 1-10.
33. MERICKEL, A. & EDWARDS, R.H. (1995). Transport of histamine by vesicular monoamine transporter-2. Neuropharmacology, 34, 1543-1547.
34. MILLER, D.D., FOWBLE, J. & PATIL, P.N. (1973). Inhibition of catecholamine uptake by conformationally restricted phenethylamine derivatives. J. Med. Chem., 16, 177-178.
35. NICHOLS, A.J. & RUFFOLO, R.R. (1991). Structure-activity relationships for alpha-adrenoceplor agonists and antagonists. In Alpha-Adrenoceptors: Molecular Biology, Biochemistry and Pharmacology, ed. Ruffolo, R.R. Basel: Karger.
36. PACHOLCZYK, T., BLAKELY, R.D. & AMARA, S.G. (1991). Expression-cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter. Nature, 350, 350-354.
37. PETER, D., JIMENEZ, J., LIU, Y., KIM, J. & EDWARDS, R.H. (1994). The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J. Biol. Chem., 269, 7231-7237.
38. PULLMAN, B., COUBEILS, J.L., COURRIERE, P. & GERVOIS, J.P. (1972). Quantum mechanical study of the conformational properties of phenethylamines of biochemical and medicinal interest. J. Med. Chem., 15, 17-23.
39. RUFFOLO, R.R., DEMARINIS, R.M., WISE, M. & HIEBLE, J.P. (1988). Structure-activity relationships for alpha-2 adrenergic receptor agonists and antagonists. In The Alpha-2 Adrenergic Receptors. ed. Limbird, L.E. Clifton, New Jersey: Humana Press.
40. 2 in the isolated rat heart by steroids, clonidine and methoxylated phenylethylamines. Eur. J. Pharmacol., 20, 329-340.
41. 2). Naunyn-Schmiedeberg's Arch. Pharmacol., 345, 437-443.
42. SCHULDINER, S., SHIRVAN, A. & LINIAL, M. (1995). Vesicular neurotransmitter transporters. Physiol. Rev., 75, 369-392.
43. SLOTKIN, T.A., ANDERSON, T.R., SEIDLER, F.J. & LAU, C. (1975). Inhibition of epinephrine and metaraminol uptake into adrenal medullary vesicles by aralkylamines and alkylamines. Biochem. Pharmacol. 24, 1413-1419.
44. SLOTKIN, T.A. & KIRSHNER, N. (1971). Uptake, storage and distribution of amines in bovine adrenal medullary vesicles. Mol. Pharmacol., 7, 581-592.
45. 3H]norepinephrine uptake into rat brain synaptic vesicles by beta carboline, indolealkylamine, phenethylamine and n-alkylamine derivatives. Mol. Pharmacol., 15, 607-619.
46. SMITH, P.K., KROHN, R.I., HERMANSON, G.T., MALLIA, A.K., GARTNER, F.H., PROVENZANO, M.D., FUJIMOTO, E.K., GOEKE, N.M., OLSON, B.J. & KLENK, D.C. (1985). Measurement of protein using bicinchoninic acid. Analyt. Biochem., 150, 76-85.
47. THORNBURG, J.E. & MOORE, K.E. (1973). Dopamine and norepinephrine uptake by rat brain synaptosomes: relative inhibitory potencies of I-and d-amphetamine and amantadine. Res. Commun. Chem. Pathol. Pharmacol., 5, 81-89.
48. WEINER, R.I., WETSEL, W , GOLDSMITH, P., MARTINEZ DE LA ESCALARA, G., WINDLE, J., PADULA, C., CHOI, A., NEGROVILAR, A. & MELLON, P. (1992). Gonadotrophin-releasing hormone neuronal cell lines. Frontiers Neuroendocrinol., 13, 95-119.
49. WHITE, S. & AL-DAMLUJI, S. (1997). Molecular cloning of alpha-1 adrenergic receptor cDNA from GnRH neurones. J. Endocrinol., 152 (supplement), abstract P150.